SuperworthAnnovis Bio shares outstanding ANVS
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 37.5M
- On a year earlier
- +92.5%
- more shares
Annovis Bio had 37.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 92.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 25.5M | +76% |
| FY2024 | 14.5M | +47% |
| FY2023 | 9.9M | +21% |
| FY2022 | 8.2M | +1% |
| FY2021 | 8.1M | +18% |
| FY2020 | 6.9M | +2338% |
| FY2019 | 282.6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 37.5M | +93% | |
| Q1 FY26 | 27.8M | +60% | |
| Q4 FY25 | 25.5M | +76% | |
| Q3 FY25 | 19.7M | +52% | |
| Q2 FY25 | 19.5M | +72% | |
| Q1 FY25 | 17.4M | +61% | |
| Q4 FY24 | 14.5M | +47% | |
| Q3 FY24 | 13M | +44% | |
| Q2 FY24 | 11.3M | +26% | |
| Q1 FY24 | 10.8M | +32% | |
| Q4 FY23 | 9.9M | +21% | |
| Q3 FY23 | 9M | +10% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Annovis Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.